Skip to search formSkip to main contentSkip to account menu

A-56268

Known as: A 56268, A56268, Abbott-56268 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1989
1989
TE-031 (A-56268), a new macrolide antibiotics, was administered on a long-term basis (6 months) to 12 patients with diffuse… 
Highly Cited
1989
Highly Cited
1989
A comparison of agar dilution and microdilution susceptibility testing for eight antimicrobial agents, including roxithromycin… 
1989
1989
The activity of a new macrolide, TE-031 (A-56268), against Legionella pneumophila in vitro was superior to the activities of… 
Highly Cited
1988
Highly Cited
1988
The in vitro activity of azithromycin (CP 62,993 or XZ-450) against Haemophilus influenzae was greater than that of three other… 
1988
1988
The activity of A-56268 (TE-031), a new macrolide, was tested in a murine model of acute toxoplasmosis. All control animals died… 
1988
1988
The inhibitory (MIC) and bactericidal (MBC) activities of a new macrolide A-56268 (TE-031) against 306 clinical aerobic bacterial… 
1987
1987
The in vitro activity of A-56268 was determined and compared with that of erythromycin and clindamycin against a limited spectrum… 
1987
1987
The comparative in-vitro activity of A-56268 (TE-031), a new semisynthetic macrolide antibiotic, was assessed against… 
1987
1987
A-56268 is a 6-O-methyl derivative of erythromycin A which has a spectrum of activity similar to that of erythromycin and is 1…